Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
Finlay Aleck McAlisterBrendan Cord LethebeCaitlin LambeTyler WilliamsonMark LowerisonPublished in: Cardiovascular diabetology (2018)
Glycemic and hypertensive control exhibited statistically significant but small magnitude differences across frailty states. Medication deintensification was uncommon, even in frail patients below SBP and HbA1C targets. SBP levels were more likely to be outside recommended treatment ranges than glycemic levels. Trial registration As this study is a retrospective secondary analysis of electronic medical record data and not a health care intervention trial it was not registered.
Keyphrases
- healthcare
- blood pressure
- type diabetes
- study protocol
- end stage renal disease
- randomized controlled trial
- phase iii
- clinical trial
- ejection fraction
- public health
- chronic kidney disease
- phase ii
- newly diagnosed
- glycemic control
- mental health
- prognostic factors
- electronic health record
- hypertensive patients
- stem cells
- community dwelling
- health information
- heart rate
- metabolic syndrome
- combination therapy
- big data
- open label
- mesenchymal stem cells
- smoking cessation
- placebo controlled